CorAssist Cardiovascular - Innovative Solutions for heart failure with preserved ejection fraction (HFpEF)
CorAssist is committed to developing innovative
therapeutic products for treating
heart failure with preserved
ejection fraction.
CorAssist Cardiovascular - Innovative Solutions for Heart Failure with Preserved Ejection Fraction (HFpEF)

Articles

  • Epidemiology and burden of heart failure with preserved ejection fraction

    • 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
    • 'Gara P.T., M.D., FACC, FAHA. et al. J Am Coll Cardiol. 2013, 61(4):e78-e140.
    • Epidemiology and clinical course of heart failure with preserved ejection fraction Lam C.S. et al., European Journal of Heart Failure, 2011, 13(1), 18-28.
    • ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012
      McMurray J.J., European Heart Journal, 2012, 33(14), 1787–1847.
    • Heart Disease and Stroke Statistics--2014 Update
      Alan S. Go. M.D., et al., Circulation. 2014 , 129, e28-e292.
    • Trends in Prevalence and Outcome of Heart Failure with Preserved Ejection Fraction
      Owan T.E., M.D., et al. n engl j med. 2006, 355, 251-259.

  • Heart failure with preserved ejection fraction: Clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial

    McMurray J.J., et al., European Journal of Heart Failure , 2008, 10(2), 149–156.

  • Discriminating clinical features of heart failure with preserved vs. reduced ejection fraction in the community

    Ho J.E., et al. Eur Heart J. 2012, 33(14), 1734-41.

  • How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology

    Paulus W., et al., Eur Heart J., 2007, 28(20), 2539-50.

  • Irbesartan in Patients with Heart Failure and Preserved Ejection Fraction

    Massie B.M., M.D., et al. for the I-PRESERVE Investigators. n engl j med. 2008. 359. 2456-2467.

  • Preoperative moderate to severe diastolic dysfunction: A novel Doppler echocardiographic long-term prognostic factor in patients with severe aortic stenosis

    Peter Gjertsson, MD Kenneth Caidahl, MD, PhD Mahmood Farasati, MSc Anders Odén, PhD Odd Bech-Hanssen, MD, PhD
    J Thorac Cardiovasc Surg. 2005, 129(4), 890-6.

  • Large animal models for diastolic dysfunction and diastolic heart failure - a review of the literature

    Dubi S, Arbel Y., Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Cardiovasc Pathol. 2010, 19(3). 147-52.
    PMID: 19211273; February 2009

  • Energy transfer from systole to diastole: a novel device-based approach for the treatment of diastolic heart failure

    Yair Feld, Shay Dubi, Yotam Reisner, Ehud Schwammenthal, Rona Shofti, Alon Pinhasi, Shemy Carasso, Amir Elami,
    Acute Cardiac Care. 2011, 13 232-242.

  • Future Strategic for the Treatment of diastolic Heart Failure

    Yair Feld, Shay Dubi, Yotam Reisner, Ehud Schwammenthal and Amir Elami,
    Acute Cardiac Care. 2006, 8 13-20.